David Nolan
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Emergency Medicine top 0.1%
- HIV-related health complications and treatments
Papers in
-
- HIV-related health complications and treatments 39
- Virology 36
- HIV Research and Treatment 36
- Co-authors
- S. Mallal (72 shared papers)Ian James (26 shared papers)A. Martin (15 shared papers)E. McKinnon (24 shared papers)Elizabeth J. Phillips (11 shared papers)Corey Moore (6 shared papers)E. Hammond (19 shared papers)Mina John (16 shared papers)
- Journals
- AIDS (9 papers)Antiviral Therapy (7 papers)PLoS ONE (5 papers)Journal of Virology (3 papers)HIV Medicine (3 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
David Nolan
140 papers receiving 7.4k citations
David Nolan's Hit Papers
Peers
Comparison fields: 5 of 138
- Virology 1.5k
- Emergency Medicine 1.4k
- Pharmacology 2.3k
- Infectious Diseases 1.7k
- Pharmacology 811
Countries citing papers authored by David Nolan
This map shows the geographic impact of David Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nolan more than expected).
Fields of papers citing papers by David Nolan
This network shows the impact of papers produced by David Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nolan. The network helps show where David Nolan may publish in the future.
Co-authors
The 25 scholars most cited alongside David Nolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HLA-B*5701 Screening for Hypersensitivity to Abacavir Hit paper breakdown → | 2008 | 1314 |
| 2 | Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Hit paper breakdown → | 2002 | 1094 |
| 3 | 2004 | 355 | |
| 4 | 2006 | 316 | |
| 5 | 2008 | 265 | |
| 6 | 2004 | 252 | |
| 7 | 2006 | 230 | |
| 8 | 2003 | 221 | |
| 9 | 2005 | 162 | |
| 10 | 2001 | 137 | |
| 11 | 2006 | 110 | |
| 12 | 2003 | 107 | |
| 13 | 2005 | 103 | |
| 14 | 2005 | 96 | |
| 15 | 2003 | 96 | |
| 16 | 2001 | 89 | |
| 17 | 2004 | 83 | |
| 18 | 2003 | 76 | |
| 19 | 2013 | 75 | |
| 20 | 2003 | 73 |
About David Nolan
David Nolan is a scholar working on Emergency Medicine, Virology, Pharmacology, Infectious Diseases and Immunology, having authored 150 papers that have together received 7.8k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (39 papers), HIV Research and Treatment (36 papers), Drug-Induced Adverse Reactions (26 papers), HIV/AIDS drug development and treatment (25 papers), Urticaria and Related Conditions (10 papers), Musculoskeletal pain and rehabilitation (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and HIV/AIDS Research and Interventions (8 papers). The work is most often cited by research in Virology (1.5k citations), Emergency Medicine (1.4k citations), Pharmacology (2.3k citations), Infectious Diseases (1.7k citations) and Pharmacology (811 citations). David Nolan has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include S. Mallal, Ian James, A. Martin, E. McKinnon, Elizabeth J. Phillips, Corey Moore, E. Hammond, Mina John, Silvana Gaudieri and Cyril Mamotte. Their work appears in journals such as AIDS, Antiviral Therapy, PLoS ONE, Journal of Virology and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.